Company: ARTL
Filing Date: 2025-12-11
Form Type: DEF 14A
Source: 0001640334-25-002308
Chunk: 11

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-12-11
Form: DEF 14A
Chunk 11
---
orgas, (iv) 3,008 shares of Common Stock held directly by Mr. Gorgas, (v) 400 shares of Common Stock held indirectly by Gorgas Family Trust and (vi) 51,131 shares of Common Stock issuable pursuant to options held directly by Mr. Gorgas exercisable within 60 days of December 10, 2025. On October 28, 2025, the Company entered into a Subscription Agreement pursuant to which it issued and sold to certain investors (the “Investors”), and the Investors purchased (by converting all or a portion of the unconverted “Voluntary Conversion” portion of unpaid principal balance and accrued interest due to such Investors upon the maturity of the convertible promissory notes issued to the Investors on May 1, 2025): (i) convertible notes (the “October 2025 Notes”) to the Investors in an aggregate principal amount of $690,154.69; and (ii) warrants (the “October 2025 Warrants”) to purchase an aggregate of 438,182 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), at an exercise price of $3.40 per share. On May 1, 2025, the Company issued certain convertible promissory notes, the “Automatic Conversion” portion of which was converted into warrants to purchase an aggregate of 246,498 shares of the Company’s common stock. For more information regarding the October 2025 Notes, the October 2025 Warrants and the May 2025 Warrants, see the Form 8-K filed by the Company on October 31, 2025. |
| (2) | Consists of (i) 34,578 shares of Common Stock issuable upon conversion of the October 2025 Note held by Ms. Matsui, (ii) 38,346 shares of Common Stock issuable upon exercise of the May 2025 Warrants, (iii) 70,376 shares of Common Stock issuable upon exercise of the October 2025 Warrants, (iv) 630 shares held directly by Ms. Matsui and (v) 3,416 shares of Common Stock issuable pursuant to options held directly by Ms. Matsui exercisable within 60 days of December 10, 2025. As a result of the beneficial ownership limitation of the October 2025 Notes, the May 2025 Warrants and the October